Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Polymorphism associated with cholesterol and risk of cardiovascular events

Kathiresan, Sekar ; Melander, Olle LU orcid ; Anevski, Dragi LU ; Guiducci, Candace ; Burtt, Noël ; Roos, Charlotta LU ; Hirschhorn, Joel N ; Berglund, Göran LU ; Hedblad, Bo LU and Groop, Leif LU , et al. (2008) In New England Journal of Medicine 358(12). p.1240-1249
Abstract
Background Common single-nucleotide polymorphisms (SNPs) that are associated with blood low-density lipoprotein (LDL) or high-density lipoprotein (HDL) cholesterol modestly affect lipid levels. We tested the hypothesis that a combination of such SNPs contributes to the risk of cardiovascular disease.



Methods We studied SNPs at nine loci in 5414 subjects from the cardiovascular cohort of the Malmö Diet and Cancer Study. We first validated the association between SNPs and either LDL or HDL cholesterol and subsequently created a genotype score on the basis of the number of unfavorable alleles. We used Cox proportional-hazards models to determine the time to the first cardiovascular event in relation to the genotype... (More)
Background Common single-nucleotide polymorphisms (SNPs) that are associated with blood low-density lipoprotein (LDL) or high-density lipoprotein (HDL) cholesterol modestly affect lipid levels. We tested the hypothesis that a combination of such SNPs contributes to the risk of cardiovascular disease.



Methods We studied SNPs at nine loci in 5414 subjects from the cardiovascular cohort of the Malmö Diet and Cancer Study. We first validated the association between SNPs and either LDL or HDL cholesterol and subsequently created a genotype score on the basis of the number of unfavorable alleles. We used Cox proportional-hazards models to determine the time to the first cardiovascular event in relation to the genotype score.



Results All nine SNPs showed replication of an association with levels of either LDL or HDL cholesterol. With increasing genotype scores, the level of LDL cholesterol increased from 152 mg to 171 mg per deciliter (3.9 to 4.4 mmol per liter), whereas HDL cholesterol decreased from 60 mg to 51 mg per deciliter (1.6 to 1.3 mmol per liter). During follow-up (median, 10.6 years), 238 subjects had a first cardiovascular event. The genotype score was associated with incident cardiovascular disease in models adjusted for covariates including baseline lipid levels (P<0.001). The use of the genotype score did not improve the clinical risk prediction, as assessed by the C statistic. However, there was a significant improvement in risk classification with the use of models that included the genotype score, as compared with those that did not include the genotype score.



Conclusions A genotype score of nine validated SNPs that are associated with modulation in levels of LDL or HDL cholesterol was an independent risk factor for incident cardiovascular disease. The score did not improve risk discrimination but did modestly improve clinical risk reclassification for individual subjects beyond standard clinical factors. (Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; ; ; and (Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
New England Journal of Medicine
volume
358
issue
12
pages
1240 - 1249
publisher
Massachusetts Medical Society
external identifiers
  • wos:000254094400005
  • scopus:40949149395
ISSN
0028-4793
language
English
LU publication?
yes
id
991251a0-9a89-4e6f-9663-597408f73bc8 (old id 1144442)
alternative location
http://content.nejm.org/cgi/content/full/358/12/1240
date added to LUP
2016-04-01 12:06:56
date last changed
2024-05-07 04:04:30
@article{991251a0-9a89-4e6f-9663-597408f73bc8,
  abstract     = {{Background Common single-nucleotide polymorphisms (SNPs) that are associated with blood low-density lipoprotein (LDL) or high-density lipoprotein (HDL) cholesterol modestly affect lipid levels. We tested the hypothesis that a combination of such SNPs contributes to the risk of cardiovascular disease.<br/><br>
<br/><br>
Methods We studied SNPs at nine loci in 5414 subjects from the cardiovascular cohort of the Malmö Diet and Cancer Study. We first validated the association between SNPs and either LDL or HDL cholesterol and subsequently created a genotype score on the basis of the number of unfavorable alleles. We used Cox proportional-hazards models to determine the time to the first cardiovascular event in relation to the genotype score.<br/><br>
<br/><br>
Results All nine SNPs showed replication of an association with levels of either LDL or HDL cholesterol. With increasing genotype scores, the level of LDL cholesterol increased from 152 mg to 171 mg per deciliter (3.9 to 4.4 mmol per liter), whereas HDL cholesterol decreased from 60 mg to 51 mg per deciliter (1.6 to 1.3 mmol per liter). During follow-up (median, 10.6 years), 238 subjects had a first cardiovascular event. The genotype score was associated with incident cardiovascular disease in models adjusted for covariates including baseline lipid levels (P&lt;0.001). The use of the genotype score did not improve the clinical risk prediction, as assessed by the C statistic. However, there was a significant improvement in risk classification with the use of models that included the genotype score, as compared with those that did not include the genotype score.<br/><br>
<br/><br>
Conclusions A genotype score of nine validated SNPs that are associated with modulation in levels of LDL or HDL cholesterol was an independent risk factor for incident cardiovascular disease. The score did not improve risk discrimination but did modestly improve clinical risk reclassification for individual subjects beyond standard clinical factors.}},
  author       = {{Kathiresan, Sekar and Melander, Olle and Anevski, Dragi and Guiducci, Candace and Burtt, Noël and Roos, Charlotta and Hirschhorn, Joel N and Berglund, Göran and Hedblad, Bo and Groop, Leif and Altshuler, David M and Newton-Cheh, Christopher and Orho-Melander, Marju}},
  issn         = {{0028-4793}},
  language     = {{eng}},
  number       = {{12}},
  pages        = {{1240--1249}},
  publisher    = {{Massachusetts Medical Society}},
  series       = {{New England Journal of Medicine}},
  title        = {{Polymorphism associated with cholesterol and risk of cardiovascular events}},
  url          = {{http://content.nejm.org/cgi/content/full/358/12/1240}},
  volume       = {{358}},
  year         = {{2008}},
}